Morning Market Losers

shares tumbled 33.18 percent to $24.39 after the company reported weaker-than-expected Q3 results and lowered its FY15 earnings outlook

shares dipped 31.58 percent to $11.05 following Wednesday's FDA approval of the company's treatment for Hyperkalemia.

shares fell 29.79 percent to $28.47 after the company reported weak Q3 operating results.

dropped 21.06 percent to $17.65 on downbeat Q2 results.

shares slipped 17.81 percent to $28.61 after falling 4.47 percent on Wednesday. Mizuho Securities downgraded Tenet Healthcare from Buy to Neutral and lowered the price target from $68.00 to $30.00.

fell 14.51 percent to $73.18. Adeptus Health reported Q3 earnings of $0.31 per share on revenue of $88.2 million.

shares dropped 13.68 percent to $35.97 on weaker-than-expected Q3 results.

shares declined 9.97 percent to $31.71 after the company issued a weak Q4 forecast.

shares slipped 5.84 percent to $72.04 after the company reported weaker-than-expected earnings for the third quarter.

shares dropped 4.72 percent to $14.13 after the company reported the US PTO issuance of added notice of allowance with claims covering PENNSAID 2%.